Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
激酶受损的 BTK 突变易受临床阶段 BTK 和 IKZF1/3 降解剂 NX-2127 的影响
期刊:Science
影响因子:44.7
doi:10.1126/science.adi5798
Skye Montoya #, Jessie Bourcier #, Mark Noviski #, Hao Lu #, Meghan C Thompson, Alexandra Chirino, Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan Sievers, Paul Auger, Hugo Bousquet, Nivetha Brat